Naprosyn (Naproxen)

Naproxen works by blocking the cyclooxygenase (COX) enzymes, COX‑1 and COX‑2, which are essential for the production of prostaglandins. By reducing prostaglandin synthesis, naproxen diminishes the inflammatory response, alleviates pain signals, and lowers body temperature during fever.

The dosage of Naprosyn is individualized by the prescribing clinician based on the patient’s condition, severity of symptoms, and overall health status. Healthcare professionals determine the appropriate strength, frequency, and duration of therapy according to current clinical guidelines.

Safety data for naproxen during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider after a thorough risk‑benefit assessment.

To place an order, submit an enquiry on the Naprosyn product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Both naproxen (Naprosyn) and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a quicker onset. Safety profiles are comparable, but individual patient factors such as gastrointestinal tolerance and cardiovascular risk influence the choice between them.

Naprosyn suppositories should be stored at room temperature, below 25 °C, in their original packaging to protect them from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme heat.

Naprosyn is supplied as a rectal suppository. The patient should lie on their side with the lower leg drawn toward the abdomen, gently insert the suppository into the rectum, and remain lying down for a few minutes to ensure proper absorption. Hand washing before and after insertion is recommended.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, acute kidney injury, severe skin reactions like Stevens‑Johnson syndrome, and liver dysfunction. Patients should be educated to seek immediate medical attention if they experience symptoms such as severe abdominal pain, black stools, sudden swelling, or rash.

Naprosyn should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and in patients who have had a recent coronary artery bypass graft. It is also contraindicated in those taking certain anticoagulants without close medical supervision.